Promoting Palliative Care for People With Heart Failure
Launched by YALE UNIVERSITY · Apr 11, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving care for people with heart failure by developing a new tool that helps healthcare providers decide when to refer patients to palliative care. Palliative care is specialized support that helps patients manage serious illnesses and improve their quality of life. The tool uses a method to predict how long a patient might live after being hospitalized, which can help doctors make better decisions about the care that aligns with patients' needs and goals.
To be eligible for this trial, healthcare providers must be part of the hospital teams that treat patients with heart failure and have certain roles, like doctors or advanced practice nurses. Patients who might be included are those hospitalized for heart failure, showing specific test results, and who have received certain treatments during their stay. While the study is not yet recruiting participants, it aims to enhance communication and decision-making in heart failure care, ultimately leading to better outcomes for patients and their families.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Healthcare providers must meet the following criteria:
- • Are an attending physician, fellow, or resident, advanced practice nurse, or physician associate
- • Has ordering privileges
- • Are members of one of the hospitals' admitting teams (e.g., hospitalist service, cardiology service)
- • Anticipate employment at one of the two study sites for the 15-month trial period.
- • Or
- • Palliative care team member
- • Hospital administrator/quality and safety personnel
- Patients of providers enrolled in the study must meet the following criteria for heart failure during hospitalization:
- • N-terminal pro-B-type natriuretic peptide values of \>500 pg/ml
- • Not pregnant at the time of admission.
- • Received intravenous diuretics within 24 hours of admission.
- Exclusion Criteria:
- • -
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Haven, Connecticut, United States
New Haven, Connecticut, United States
Patients applied
Trial Officials
Shelli Feder, PhD
Principal Investigator
Yale University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported